Tyra Biosciences TYRA
NASDAQ TYRA
$20.43 -0.58 (-2.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tyra Biosciences (TYRA) Cash & Equivalents (2020 - 2026)

Updated

Tyra Biosciences (TYRA) posted Cash & Equivalents of $73.84 million for Q2 2026, down 25.0% from $98.49 million a year earlier and down 13.1% from the prior quarter.

Analysis

Tyra Biosciences (TYRA) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Tyra Biosciences' Cash & Equivalents came in at $77.39 million, down 15.9% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of 38.4% (FY2020 to FY2025).
  • In prior years, Tyra Biosciences' Cash & Equivalents was $91.97 million in FY2024 (+58.5%), $58.01 million in FY2023 (-76.9%), $251.21 million in FY2022 (-16.9%) and $302.18 million in FY2021.
  • Quarterly Cash & Equivalents has run from a low of $58.01 million in Q4 2023 to a high of $312.82 million in Q3 2021 over five years.
  • On a year-over-year basis, Cash & Equivalents has declined in each of the last six quarters, with an average decline of 18.9% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 108.0%; the weakest was Q4 2023, with a decline of 76.9%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $84.96 million (Q1 2026), $77.39 million (Q4 2025) and $61.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Tyra Biosciences 1.22 Bn 1.22 Bn - 73.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73.84 Mn
Mar 31, 2026 84.96 Mn
Dec 31, 2025 77.39 Mn
Sep 30, 2025 61.95 Mn
Jun 30, 2025 98.49 Mn
Mar 31, 2025 100.72 Mn
Dec 31, 2024 91.97 Mn
Sep 30, 2024 103.89 Mn
Jun 30, 2024 99.49 Mn
Mar 31, 2024 254.37 Mn
Dec 31, 2023 58.01 Mn
Sep 30, 2023 215.65 Mn
Jun 30, 2023 232.41 Mn
Mar 31, 2023 241.70 Mn
Dec 31, 2022 251.21 Mn
Sep 30, 2022 263.21 Mn
Jun 30, 2022 275.11 Mn
Mar 31, 2022 292.50 Mn
Dec 31, 2021 302.18 Mn
Sep 30, 2021 312.82 Mn
API Access

Tyra Biosciences Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TYRA&period=max&api_key=YOUR_API_KEY